SBFM SUNSHINE BIOPHARMA INC
FollowCOMMON STOCK (common), issuer CIK 1402328
Filings received so far for Q3 2026: 15 13F filers report a position in SBFM shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- CVI Investments, Inc.(group HEIGHTS CAPITAL MANAGEMENT, INC)
1,588,266 shares, 9.9% in a 13G as of 2026-10-08,0001649553-26-000116
Accepted , ingested - BJI Financial Group
909,900 shares, 6% in a 13G as of 2026-10-08,0002063341-26-000003
Accepted , ingested - INTRACOASTAL CAPITAL, LLC (group INTRACOASTAL CAPITAL, LLC)
430,336 shares, 9.99% in a 13G/A as of 2026-09-30,0001213900-26-118164
Accepted , ingested - Alta Partners LLC
200,000 shares, 4.9% in a 13G/A as of 2026-08-13,0001094891-26-000296
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Events
INTRACOASTAL CAPITAL, LLC and 2 other reporting persons reported 430,336 SBFM shares, 9.99% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-10. 0001213900-26-118164
Accepted , ingestedBJI Financial Group reported 909,900 SBFM shares, 6% of the class, as of 2026-10-08, in a 13G filed 2026-10-14. 0002063341-26-000003
Accepted , ingestedCVI Investments, Inc. and 1 other reporting person reported 1,588,266 SBFM shares, 9.9% of the class, as of 2026-10-08, in a 13G filed 2026-10-13. 0001649553-26-000116
Accepted , ingestedAlta Partners LLC reported 200,000 SBFM shares, 4.9% of the class, as of 2026-08-13, in a 13G/A filed 2026-10-05. 0001094891-26-000296
Accepted , ingested